Association of Height with Mortality in Patients Undergoing Maintenance Hemodialysis

被引:9
|
作者
Shapiro, Bryan B. [1 ,2 ]
Streja, Elani [1 ]
Ravel, Vanessa A. [1 ]
Kalantar-Zadeh, Kamyar [1 ,3 ,4 ]
Kopple, Joel D. [2 ,3 ,5 ]
机构
[1] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Harold Simmons Ctr Kidney Dis Res & Epidemiol, Torrance, CA 90502 USA
[2] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Nephrol & Hypertens, Torrance, CA 90502 USA
[3] UCLA Fielding Sch Publ Hlth, Los Angeles, CA USA
[4] Univ Calif Irvine, Div Nephrol & Hypertens, Orange, CA 92668 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
PULSE-WAVE VELOCITY; BODY-MASS INDEX; ADULT HEIGHT; CARBONYL STRESS; UREMIC TOXINS; SHORT STATURE; RISK; DIALYSIS; CANCER; COHORT;
D O I
10.2215/CJN.07970814
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Body mass index (BMI), determined as kilograms in body weight divided by the square of the height in meters (m(2)), is inversely associated with mortality in patients undergoing maintenance hemodialysis (MHD). It is commonly inferred that differences in the weight component of the BMI equation are responsible for this negative correlation. However, there are almost no data on the relationship between height and mortality in these patients. This study was conducted to examine the association between height and mortality in MHD patients and to evaluate the contribution of height to the BMI-mortality relationship. Design, setting, participants, & measurements A prospective study conducted from July 1, 2001, through June 30, 2006, enrolled a nationally representative cohort of 117,644 MHD patients receiving treatment in DaVita, Inc. outpatient dialysis facilities with (1) known height and weight, (2) age years, (3) dialysis vintage >= 90 days, and (4) nonoutlying BMI values (>= 12 to <= 60 kg/m(2)). The end date of follow-up was June 30, 2007, and median follow-up was 852 days (interquartile range, 504-1367 days). Mortality hazard ratios were computed within sex-standardized deciles of height and weight, and outcomes included all-cause mortality and cardiovascular, gastrointestinal, cancer, and infection mortality. Hazard models were unadjusted, adjusted for case-mix variables, or adjusted for case-mix variables plus laboratory variables. Results Mean age was 61 +/- 15 years; 45% of patients were women and 57% had diabetes. In adjusted models, height, also adjusted for weight, was directly associated with all-cause mortality and cardiovascular, infection, and cancer mortality. Compared with the median height decile, mortality risk in the highest height decile was 1.18 (95% confidence interval, 1.14 to 1.23) in fully adjusted analyses (P<0.001). Receiver-operating characteristic curves indicated that in adjusted analyses the contribution of height to the relationship between BMI and mortality was almost identical to that of weight. Conclusions In MHD patients, height is positively associated with mortality risk and contributes similarly to weight with regard to the negative BMI-mortality relationship.
引用
收藏
页码:965 / 974
页数:10
相关论文
共 50 条
  • [31] Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis
    Saglimbene, Valeria M.
    Wong, Germaine
    Ruospo, Marinella
    Palmer, Suetonia C.
    Garcia-Larsen, Vanessa
    Natale, Patrizia
    Teixeira-Pinto, Armando
    Campbell, Katrina L.
    Carrero, Juan-Jesus
    Stenvinkel, Peter
    Gargano, Letizia
    Murgo, Angelo M.
    Johnson, David W.
    Tonelli, Marcello
    Gelfman, Ruben
    Celia, Eduardo
    Ecder, Tevfik
    Bernat, Amparo G.
    Del Castillo, Domingo
    Timofte, Delia
    Torok, Marietta
    Bednarek-Skublewska, Anna
    Dulawa, Jan
    Stroumza, Paul
    Hoischen, Susanne
    Hansis, Martin
    Fabricius, Elisabeth
    Felaco, Paolo
    Wollheim, Charlotta
    Hegbrant, Jorgen
    Craig, Jonathan C.
    Strippoli, Giovanni F. M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (02): : 250 - 260
  • [32] SPURIOUS HYPOCALCEMIA IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS
    COBURN, JW
    MASSRY, SG
    GORDON, S
    RUBINI, ME
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1969, 52 (05) : 572 - &
  • [33] VIBROTACTILE THRESHOLD IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS
    EDWARDS, AE
    KOPPLE, JD
    KORNFELD, CM
    ARCHIVES OF INTERNAL MEDICINE, 1973, 132 (05) : 706 - 708
  • [34] VITAMIN NUTRITION IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS
    KOPPLE, JD
    SWENDSEID, ME
    KIDNEY INTERNATIONAL, 1975, 7 (01) : S79 - S84
  • [35] Vancomycin dosing in patients undergoing maintenance hemodialysis
    Rymarz, Aleksandra
    Brodowska-Kania, Dorota
    Gomolka, Malgorzata
    Jozefczak-Bergier, Elzbieta
    Dzierzanowska, Malgorzata
    Niemczyk, Stanislaw
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (08) : 1681 - 1682
  • [36] Vancomycin dosing in patients undergoing maintenance hemodialysis
    Aleksandra Rymarz
    Dorota Brodowska-Kania
    Małgorzata Gomółka
    Elżbieta Józefczak-Bergier
    Małgorzata Dzierżanowska
    Stanisław Niemczyk
    International Urology and Nephrology, 2014, 46 : 1681 - 1682
  • [37] IRON THERAPY IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS
    MILMAN, N
    ACTA MEDICA SCANDINAVICA, 1976, 200 (04): : 315 - 319
  • [38] THE STOMACH DUODENUM IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS
    KANG, JY
    WU, AYT
    SUTHERLAND, IE
    DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) : S78 - S78
  • [39] Garenoxacin pharmacokinetics in patients undergoing maintenance hemodialysis
    Aoyama, Togo
    Kamata, Kouju
    Kishino, Satoshi
    HEMODIALYSIS INTERNATIONAL, 2017, 21 (02) : 206 - 212
  • [40] Association between dialysis schedule and mortality in maintenance hemodialysis
    Prabhavalkar, Siddhesh M.
    Mullan, Robert N.
    Cunningham, Ronan G. C.
    Harron, Camille J.
    KIDNEY INTERNATIONAL, 2012, 82 (09) : 1034 - 1035